Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 28, 2015 5:03 AM ET

Life Sciences Tools and Services

Company Overview of Synexus Limited

Company Overview

Synexus Limited engages in the identification, recruitment, and retention of patients for clinical trials on behalf of sponsors that include pharmaceutical companies, biotech companies, and contract research organizations worldwide. The company offers feasibility assessment, consultancy, project management, and medical imaging services. Its therapeutic areas include cardiovascular, CNS, endocrinology and metabolism, musculoskeletal, respiratory, dermatology, ENT, gastroenterology, infectious diseases, ophthalmology, urology, women’s health, screenable medical conditions, and others. The company was founded in 1998 and is headquartered in Chorley, United Kingdom. It has research centres in th...

Sandringham House

Ackhurst Park

Chorley,  PR7 1NY

United Kingdom

Founded in 1998

155 Employees

Phone:

44 1257 230 723

Fax:

44 1257 231 981

Key Executives for Synexus Limited

Chief Executive Officer and Director
Age: 53
Financial Director and Director
Chief Operating Officer
Business Development Director
Head of Operations - Germany
Compensation as of Fiscal Year 2015.

Synexus Limited Key Developments

Synexus Seeks Acquisitions

Synexus Limited is looking for acquisition. Synexus intends to become a major player in the US, continue to expand its existing network of sites in Europe and Africa and develop a presence in Asia and South America.

Synexus Announces Board Appointments

Following the completion of the management buyout of Synexus the new board confirms its intention to expand the company's footprint through organic growth and acquisition. The new board members of Synexus are: Chairman Charles Woler and non-executives Benjamin Harrild, Hywel Evans, Ged Gould and Simon Braham. CEO of Synexus, Christophe Berthoux, and Financial Director of Synexus, Paul Chambers, will remain on the board. Chairman Charles Woler has spent the last 30 years in the healthcare industry, both in large multinational pharmaceutical companies, SMEs and lately in smaller, earlier stage companies - positions included Chairman and CEO of Roche France, Chairman of SmithKline Beecham's European pharmaceutical business, and CEO of Cadus Pharmaceuticals. Benjamin Harrild is the head of UK for the direct lending team of BlueBay Asset Management LLP, and was part of BlueBay's direct lending business from its inception in 2011. Hywel Evans has a wide experience in pharma and the CRO sector. His experience includes being Managing Director of Novo Nordisk UK, Managing Director of Takeda Pharmaceuticals UK, and after joining Quintiles he rose to become President of Europe. He is also Chairman of Western Sussex Hospitals NHS Trust. Ged Gould is Director and Office Head of LDC Manchester - part of the Lloyds Group - and has over 20 years of experience from the advisory arena, private equity, as well as being the Finance Director of two private equity backed businesses. Simon Braham is the Investment Director at LDC Manchester and has over 17 years' experience in advisory, banking, restructuring and private equity.

Synexus Mulls Acquisitions

After the completion of the management buyout of Synexus Limited, the new Board intends to expand through organic growth and acquisitions.

Similar Private Companies By Industry

Company Name Region
CoCo Therapeutics Ltd Europe
Pharmidex Ltd. Europe
Innova Biosciences Ltd. Europe
Catalyst Biomedica Ltd Europe
Worldwide Clinical Trials Limited Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
February 22, 2015
--
Merger/Acquisition
August 27, 2014
Synexus Helderberg Clinical Research Centre
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Synexus Limited, please visit www.synexus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.